Audioboom logo
Menu
Audioboom logo
  • Podcasts
  • Advertisers
  • Creators
  • Help & support
  • Sign up
  • Sign in
Podcasts
Advertisers
Creators
Help & support
Search podcasts
Sign up
Sign in
Podcast logo
The Vox Markets Podcast

Q&A with hVIVO’s Mo Khan

Episode 1999,   Dec 10, 2024, 09:55 AM

Headliner
See more options
Share
Facebook X
Subscribe
Watch on YouTube

hVIVO #HVO CEO, Yamin 'Mo' Khan announced an £11.5 million contract with an existing top-tier global pharmaceutical client to test an RSV antiviral candidate using hVIVO's Human Challenge Study Model. The Phase 2a trial is set to begin in the second half of 2025 at hVIVO's Canary Wharf quarantine facilities.
Share
Facebook X
Subscribe
Next
Q&A with Gunsynd Executive Chairman, Hamish Harris
Top episodes
Is a house price crash coming?
by The Vox Markets Podcast
Alastair Smith of Avacta: Successful Completion of Fourth Dose Escalation in AVA6000 Study
by The Vox Markets Podcast
Vox Markets Interview with Avacta CEO Alastair Smith
by The Vox Markets Podcast
Related episodes
Rachel Reeves Achieves More Growth, which Could Lead to Yet more Growth!
by The SharePickers Podcast with Justin Waite
Ignore the Noise, It’s All In The Numbers
by The SharePickers Podcast with Justin Waite
Expect More Volatility - Especially to The Downside
by The SharePickers Podcast with Justin Waite
  •   Report this episode
  •   Download audio
  •   QRCode
For podcasters For advertisers For listeners
Help & feedback About us Blog Investor relations
Cookie policy Privacy policy Terms & conditions
©2025 Audioboom

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

Page load failed

Please check your internet connection and refresh the page. You might also try disabling any ad blockers.

You can visit our support center if you're having problems.